Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines ...

The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for ...

Eisai and Biogen can finally put their European regulatory uncertainty surrounding Alzheimer's disease medicine Leqembi ...

Acquisition of Theravia from Mérieux Equity Partners represents meaningful step forward in Norgine's strategy for sustainable ...

Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU's radiopharmaceutical sector, according to the European Medicines Agency (EMA).Vie ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

A Pembrokeshire dairy farming family have made significant strides in reducing their antibiotics use on-farm by using ...

Leqembi approved by the EU for early-stage Alzheimer’s in patients with specific ApoE4 gene profile, marking a milestone in ...

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and enhance drug discovery processes.

China’s Chime Biologics has formed a strategic partnership with European biosimilars specialist Polpharma Biologics to ...

Tuesday approved the first vaccine against chikungunya, a viral disease transmitted by the Aedes aegypti mosquito, which also ...

The European Commission (EC) has at last granted the amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) Marketing ...